Literature DB >> 2783396

Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography.

D B Buxton1, C A Nienaber, A Luxen, O Ratib, H Hansen, M E Phelps, H R Schelbert.   

Abstract

The usefulness of [1-11C]acetate as a tracer of overall myocardial oxidative metabolism for use with positron emission tomography has been investigated in 12 closed-chest dogs. Myocardial 11C activity clearance kinetics after intravenous administration of [1-11C]acetate in dogs have been determined noninvasively by positron emission tomography. Biexponential fitting of regional myocardial 11C time-activity curves was performed to give clearance half-times and fractional distribution. The rate constant k1 for the early rapid phase of 11C activity clearance was found to correlate linearly with myocardial oxygen consumption (y = 0.0156x + 0.039; SEE = 0.023; r = 0.95). k1 was approximately 7% lower in septal sectors compared with the left ventricular free wall, suggesting that regional oxygen consumption in the septum was lower; a concomitant regional attenuation of blood flow in the septum relative to the left ventricular free wall was also observed. In dogs using carbohydrates as the predominant fuel, k1 oxygen consumption was somewhat more than in dogs using predominantly free fatty acids (0.021 +/- 0.002 compared with 0.018 +/- 0.002, p less than 0.01), indicating that increased carbohydrate consumption is associated with a small increase in k1 at constant oxygen consumption. It is concluded that measurement of myocardial [1-11C]acetate kinetics allows noninvasive determination of cardiac oxygen consumption by positron emission tomography and that the technique is relatively insensitive to myocardial fuel selection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783396     DOI: 10.1161/01.cir.79.1.134

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

1.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

Review 2.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

3.  Issues in quantification of cardiac PET studies.

Authors:  Hugo W A M de Jong; Mark Lubberink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 9.236

Review 4.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

5.  Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.

Authors:  N Tamaki; M Kawamoto; N Takahashi; Y Yonekura; Y Magata; R Nohara; H Kambara; C Kawai; J Konishi
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

Review 6.  Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease.

Authors:  P G Camici
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 7.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

8.  Assessment of myocardial oxygenation with MRI.

Authors:  Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2013-04

9.  PET Imaging of Prostate Cancer Using C-Acetate.

Authors:  Johannes Czernin; Matthias R Benz; Martin S Allen-Auerbach
Journal:  PET Clin       Date:  2009-04

10.  Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart.

Authors:  M E Jessen; T E Kovarik; F M Jeffrey; A D Sherry; C J Storey; R Y Chao; W S Ring; C R Malloy
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.